M. Awwad

Using external data to assess the external validity of a randomised controlled trial

L. Leibovici, D. Yahav, S. Harbarth, 2021, Infectious diseases.

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years.

S. Stemmer, N. Eliakim‐Raz, A. Stemmer, 2021, JAMA.

Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years

N. Moskovits, Uri Elia, S. Rotem, 2022, Journal of clinical medicine.

Characteristics of long COVID among older adults: a cross-sectional study

D. Abecasis, L. Leibovici, L. Carrozzi, 2022, International Journal of Infectious Diseases.

Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study

N. Moskovits, A. Levy-Barda, N. Erez, 2022, BMJ Open.

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

S. Stemmer, N. Eliakim‐Raz, A. Stemmer, 2022, JAMA Network Open.

Long COVID sexual dysfunction among both genders: evaluation of a cohort of COVID-19 recoverees.

L. Leibovici, I. Shapira-Lichter, D. Yahav, 2023, Infectious diseases now.